Corient Private Wealth’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.1M | Buy |
1,136,000
+824,505
| +265% | +$2.25M | ﹤0.01% | 923 |
|
|
2025
Q1 | $523K | Sell |
311,495
-871,204
| -74% | -$1.46M | ﹤0.01% | 1573 |
|
|
2024
Q4 | $1.93M | Buy |
1,182,699
+730,699
| +162% | +$1.19M | ﹤0.01% | 1020 |
|
|
2024
Q3 | $1.88M | Sell |
452,000
-155,000
| -26% | -$645K | ﹤0.01% | 1108 |
|
|
2024
Q2 | $3.31M | Buy |
607,000
+269,537
| +80% | +$1.47M | 0.01% | 826 |
|
|
2024
Q1 | $3.37M | Sell |
337,463
-75,897
| -18% | -$759K | 0.01% | 817 |
|
|
2023
Q4 | $1.69M | Buy |
413,360
+130,500
| +46% | +$532K | ﹤0.01% | 1076 |
|
|
2023
Q3 | $1.09M | Buy |
282,860
+94,500
| +50% | +$366K | ﹤0.01% | 1155 |
|
|
2023
Q2 | $1.12M | Buy |
188,360
+85,000
| +82% | +$507K | ﹤0.01% | 1104 |
|
|
2023
Q1 | $338K | Buy |
103,360
+24,682
| +31% | +$80.7K | ﹤0.01% | 1548 |
|
|
2022
Q4 | $311K | Buy |
+78,678
| New | +$311K | ﹤0.01% | 1316 |
|